<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Astellas Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Astellas Pharma, Inc.

    Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of urology, immunology including transplantation and infectious diseases, oncology, euroscience and DM complications and metabolic diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      OTCPink
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $17,682,152,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Masao Yoshida
    • FOUNDED
      2005
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Digirad Corporation

    Digirad Corporation

    Digirad delivers convenient, effective, and efficient healthcare solutions on an a...

    Digirad delivers convenient, effective, and eff...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee, we aim to radically change the way cancer is detected, monitored and tre...

    At Delee, we aim to radically change the way ca...

    Fundraising Status:    EC
    Filing Type:    CF
    Adverum Biotechnologies, Inc.

    Adverum Biotechnologies, Inc.

    Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...

    Adverum is a clinical-stage gene therapy compan...

    Filing Type:    PU
    Varex Imaging Corporation

    Varex Imaging Corporation

    We are a leading innovator and manufacturer of X-ray imaging components, including...

    We are a leading innovator and manufacturer of ...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Ritter Pharmaceuticals, Inc.

    Ritter Pharmaceuticals, Inc.

    Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the...

    Ritter Pharmaceuticals, Inc. develops novel the...

    Filing Type:    PU
    Fresenius SE & Co. KGaA

    Fresenius SE & Co. KGaA

    Fresenius is a global healthcare group offering high-quality products and services...

    Fresenius is a global healthcare group offering...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    Balchem Corporation

    Balchem Corporation

    Since 1967, Balchem Corporation (NASDAQ: BCPC) has developed and manufactured spec...

    Since 1967, Balchem Corporation (NASDAQ: BCPC) ...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.